[HTML][HTML] T1-mapping in the heart: accuracy and precision
The longitudinal relaxation time constant (T1) of the myocardium is altered in various
disease states due to increased water content or other changes to the local molecular …
disease states due to increased water content or other changes to the local molecular …
Assessment of myocardial fibrosis with cardiovascular magnetic resonance
N Mewton, CY Liu, P Croisille, D Bluemke… - Journal of the American …, 2011 - jacc.org
Diffuse interstitial or replacement myocardial fibrosis is a common feature of a broad variety
of cardiomyopathies. Myocardial fibrosis leads to impaired cardiac diastolic and systolic …
of cardiomyopathies. Myocardial fibrosis leads to impaired cardiac diastolic and systolic …
Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital …
S Fratz, T Chung, GF Greil, MM Samyn… - Journal of …, 2013 - Springer
Cardiovascular magnetic resonance (CMR) has taken on an increasingly important role in
the diagnostic evaluation and pre-procedural planning for patients with congenital heart …
the diagnostic evaluation and pre-procedural planning for patients with congenital heart …
Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans
Background—Diffuse myocardial fibrosis is a final end point in most cardiac diseases. It is
missed by the cardiovascular magnetic resonance (CMR) late gadolinium enhancement …
missed by the cardiovascular magnetic resonance (CMR) late gadolinium enhancement …
Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume
Background—Extracellular matrix expansion is a key element of ventricular remodeling and
a potential therapeutic target. Cardiovascular magnetic resonance (CMR) T1-mapping …
a potential therapeutic target. Cardiovascular magnetic resonance (CMR) T1-mapping …
[HTML][HTML] Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method
Background Disturbances in the myocardial extracellular volume fraction (ECV), such as
diffuse or focal myocardial fibrosis or edema, are hallmarks of heart disease. Diffuse ECV …
diffuse or focal myocardial fibrosis or edema, are hallmarks of heart disease. Diffuse ECV …
Athletic cardiac adaptation in males is a consequence of elevated myocyte mass
AK McDiarmid, PP Swoboda, B Erhayiem… - Circulation …, 2016 - Am Heart Assoc
Background—Cardiac remodeling occurs in response to regular athletic training, and the
degree of remodeling is associated with fitness. Understanding the myocardial structural …
degree of remodeling is associated with fitness. Understanding the myocardial structural …
T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy
F aus dem Siepen, SJ Buss… - European Heart …, 2015 - academic.oup.com
Aim The aim of this study was to determine the value of extracellular volume fraction (ECV)
for the non-invasive assessment of diffuse myocardial fibrosis (MF) in different stages of …
for the non-invasive assessment of diffuse myocardial fibrosis (MF) in different stages of …
Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease
CS Broberg, SS Chugh, C Conklin… - Circulation …, 2010 - Am Heart Assoc
Background—The etiology of ventricular dysfunction in adult congenital heart disease
(ACHD) is not well understood. Diffuse fibrosis is a likely common final pathway and is …
(ACHD) is not well understood. Diffuse fibrosis is a likely common final pathway and is …
[HTML][HTML] Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience
Background Diffuse myocardial fibrosis, and to a lesser extent global myocardial edema, are
important processes in heart disease which are difficult to assess or quantify with …
important processes in heart disease which are difficult to assess or quantify with …